The global market for Nefopam Hydrochloride Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Nefopam Hydrochloride Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Nefopam Hydrochloride Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Nefopam Hydrochloride Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Nefopam Hydrochloride Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Nefopam Hydrochloride Injection players cover Tianjin Kingyork Pharmaccuticals, Sinopharm Ronshyn Pharmaceutical, Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical, Yangtze River Pharmaceutical Group and Wanbangde Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Nefopam Hydrochloride Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Nefopam Hydrochloride Injection market, with both quantitative and qualitative data, to help readers understand how the Nefopam Hydrochloride Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Nefopam Hydrochloride Injection market and forecasts the market size by Specification (1ml/Piece and 2ml/Piece,), by Application (Hospital Pharmacy and Retail Pharmacy.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by specification
1ml/Piece
2ml/Piece
Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Tianjin Kingyork Pharmaccuticals
Sinopharm Ronshyn Pharmaceutical
Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical
Yangtze River Pharmaceutical Group
Wanbangde Pharmaceutical
Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical
Henan Tongyuan Pharmaceutical
Fuzhou FU Yao Pharmaceutical
Jumpcan Pharmaceutical Group
Shandong FANGMING Pharmaceutical
Xuzhou Ryen Pharmaceutical
Livealth
JM Lifesciences
TAJ PHARMA
Chapter Introduction
Chapter 1: Scope of Nefopam Hydrochloride Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Nefopam Hydrochloride Injection market size (sales and revenue) and CAGR, Nefopam Hydrochloride Injection market size by region, by specification, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Nefopam Hydrochloride Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Nefopam Hydrochloride Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by specification, and specification.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Nefopam Hydrochloride Injection market size forecast by region, by country, by specification, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Tianjin Kingyork Pharmaccuticals, Sinopharm Ronshyn Pharmaceutical, Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical, Yangtze River Pharmaceutical Group, Wanbangde Pharmaceutical, Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical, Henan Tongyuan Pharmaceutical, Fuzhou FU Yao Pharmaceutical and Jumpcan Pharmaceutical Group, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nefopam Hydrochloride Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Nefopam Hydrochloride Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Nefopam Hydrochloride Injection by Country/Region, 2017, 2022 & 2028
2.2 Nefopam Hydrochloride Injection Segment by Specification
2.2.1 1ml/Piece
2.2.2 2ml/Piece
2.3 Nefopam Hydrochloride Injection Sales by Specification
2.3.1 Global Nefopam Hydrochloride Injection Sales Market Share by Specification (2017-2022)
2.3.2 Global Nefopam Hydrochloride Injection Revenue and Market Share by Specification (2017-2022)
2.3.3 Global Nefopam Hydrochloride Injection Sale Price by Specification (2017-2022)
2.4 Nefopam Hydrochloride Injection Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.5 Nefopam Hydrochloride Injection Sales by Application
2.5.1 Global Nefopam Hydrochloride Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Nefopam Hydrochloride Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Nefopam Hydrochloride Injection Sale Price by Application (2017-2022)
3 Global Nefopam Hydrochloride Injection by Company
3.1 Global Nefopam Hydrochloride Injection Breakdown Data by Company
3.1.1 Global Nefopam Hydrochloride Injection Annual Sales by Company (2020-2022)
3.1.2 Global Nefopam Hydrochloride Injection Sales Market Share by Company (2020-2022)
3.2 Global Nefopam Hydrochloride Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Nefopam Hydrochloride Injection Revenue by Company (2020-2022)
3.2.2 Global Nefopam Hydrochloride Injection Revenue Market Share by Company (2020-2022)
3.3 Global Nefopam Hydrochloride Injection Sale Price by Company
3.4 Key Manufacturers Nefopam Hydrochloride Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nefopam Hydrochloride Injection Product Location Distribution
3.4.2 Players Nefopam Hydrochloride Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nefopam Hydrochloride Injection by Geographic Region
4.1 World Historic Nefopam Hydrochloride Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Nefopam Hydrochloride Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Nefopam Hydrochloride Injection Annual Revenue by Geographic Region
4.2 World Historic Nefopam Hydrochloride Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Nefopam Hydrochloride Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Nefopam Hydrochloride Injection Annual Revenue by Country/Region
4.3 Americas Nefopam Hydrochloride Injection Sales Growth
4.4 APAC Nefopam Hydrochloride Injection Sales Growth
4.5 Europe Nefopam Hydrochloride Injection Sales Growth
4.6 Middle East & Africa Nefopam Hydrochloride Injection Sales Growth
5 Americas
5.1 Americas Nefopam Hydrochloride Injection Sales by Country
5.1.1 Americas Nefopam Hydrochloride Injection Sales by Country (2017-2022)
5.1.2 Americas Nefopam Hydrochloride Injection Revenue by Country (2017-2022)
5.2 Americas Nefopam Hydrochloride Injection Sales by Specification
5.3 Americas Nefopam Hydrochloride Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nefopam Hydrochloride Injection Sales by Region
6.1.1 APAC Nefopam Hydrochloride Injection Sales by Region (2017-2022)
6.1.2 APAC Nefopam Hydrochloride Injection Revenue by Region (2017-2022)
6.2 APAC Nefopam Hydrochloride Injection Sales by Specification
6.3 APAC Nefopam Hydrochloride Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nefopam Hydrochloride Injection by Country
7.1.1 Europe Nefopam Hydrochloride Injection Sales by Country (2017-2022)
7.1.2 Europe Nefopam Hydrochloride Injection Revenue by Country (2017-2022)
7.2 Europe Nefopam Hydrochloride Injection Sales by Specification
7.3 Europe Nefopam Hydrochloride Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nefopam Hydrochloride Injection by Country
8.1.1 Middle East & Africa Nefopam Hydrochloride Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Nefopam Hydrochloride Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Nefopam Hydrochloride Injection Sales by Specification
8.3 Middle East & Africa Nefopam Hydrochloride Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nefopam Hydrochloride Injection
10.3 Manufacturing Process Analysis of Nefopam Hydrochloride Injection
10.4 Industry Chain Structure of Nefopam Hydrochloride Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nefopam Hydrochloride Injection Distributors
11.3 Nefopam Hydrochloride Injection Customer
12 World Forecast Review for Nefopam Hydrochloride Injection by Geographic Region
12.1 Global Nefopam Hydrochloride Injection Market Size Forecast by Region
12.1.1 Global Nefopam Hydrochloride Injection Forecast by Region (2023-2028)
12.1.2 Global Nefopam Hydrochloride Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nefopam Hydrochloride Injection Forecast by Specification
12.7 Global Nefopam Hydrochloride Injection Forecast by Application
13 Key Players Analysis
13.1 Tianjin Kingyork Pharmaccuticals
13.1.1 Tianjin Kingyork Pharmaccuticals Company Information
13.1.2 Tianjin Kingyork Pharmaccuticals Nefopam Hydrochloride Injection Product Offered
13.1.3 Tianjin Kingyork Pharmaccuticals Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Tianjin Kingyork Pharmaccuticals Main Business Overview
13.1.5 Tianjin Kingyork Pharmaccuticals Latest Developments
13.2 Sinopharm Ronshyn Pharmaceutical
13.2.1 Sinopharm Ronshyn Pharmaceutical Company Information
13.2.2 Sinopharm Ronshyn Pharmaceutical Nefopam Hydrochloride Injection Product Offered
13.2.3 Sinopharm Ronshyn Pharmaceutical Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sinopharm Ronshyn Pharmaceutical Main Business Overview
13.2.5 Sinopharm Ronshyn Pharmaceutical Latest Developments
13.3 Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical
13.3.1 Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical Company Information
13.3.2 Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical Nefopam Hydrochloride Injection Product Offered
13.3.3 Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical Main Business Overview
13.3.5 Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical Latest Developments
13.4 Yangtze River Pharmaceutical Group
13.4.1 Yangtze River Pharmaceutical Group Company Information
13.4.2 Yangtze River Pharmaceutical Group Nefopam Hydrochloride Injection Product Offered
13.4.3 Yangtze River Pharmaceutical Group Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Yangtze River Pharmaceutical Group Main Business Overview
13.4.5 Yangtze River Pharmaceutical Group Latest Developments
13.5 Wanbangde Pharmaceutical
13.5.1 Wanbangde Pharmaceutical Company Information
13.5.2 Wanbangde Pharmaceutical Nefopam Hydrochloride Injection Product Offered
13.5.3 Wanbangde Pharmaceutical Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Wanbangde Pharmaceutical Main Business Overview
13.5.5 Wanbangde Pharmaceutical Latest Developments
13.6 Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical
13.6.1 Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical Company Information
13.6.2 Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical Nefopam Hydrochloride Injection Product Offered
13.6.3 Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical Main Business Overview
13.6.5 Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical Latest Developments
13.7 Henan Tongyuan Pharmaceutical
13.7.1 Henan Tongyuan Pharmaceutical Company Information
13.7.2 Henan Tongyuan Pharmaceutical Nefopam Hydrochloride Injection Product Offered
13.7.3 Henan Tongyuan Pharmaceutical Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Henan Tongyuan Pharmaceutical Main Business Overview
13.7.5 Henan Tongyuan Pharmaceutical Latest Developments
13.8 Fuzhou FU Yao Pharmaceutical
13.8.1 Fuzhou FU Yao Pharmaceutical Company Information
13.8.2 Fuzhou FU Yao Pharmaceutical Nefopam Hydrochloride Injection Product Offered
13.8.3 Fuzhou FU Yao Pharmaceutical Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Fuzhou FU Yao Pharmaceutical Main Business Overview
13.8.5 Fuzhou FU Yao Pharmaceutical Latest Developments
13.9 Jumpcan Pharmaceutical Group
13.9.1 Jumpcan Pharmaceutical Group Company Information
13.9.2 Jumpcan Pharmaceutical Group Nefopam Hydrochloride Injection Product Offered
13.9.3 Jumpcan Pharmaceutical Group Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jumpcan Pharmaceutical Group Main Business Overview
13.9.5 Jumpcan Pharmaceutical Group Latest Developments
13.10 Shandong FANGMING Pharmaceutical
13.10.1 Shandong FANGMING Pharmaceutical Company Information
13.10.2 Shandong FANGMING Pharmaceutical Nefopam Hydrochloride Injection Product Offered
13.10.3 Shandong FANGMING Pharmaceutical Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Shandong FANGMING Pharmaceutical Main Business Overview
13.10.5 Shandong FANGMING Pharmaceutical Latest Developments
13.11 Xuzhou Ryen Pharmaceutical
13.11.1 Xuzhou Ryen Pharmaceutical Company Information
13.11.2 Xuzhou Ryen Pharmaceutical Nefopam Hydrochloride Injection Product Offered
13.11.3 Xuzhou Ryen Pharmaceutical Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Xuzhou Ryen Pharmaceutical Main Business Overview
13.11.5 Xuzhou Ryen Pharmaceutical Latest Developments
13.12 Livealth
13.12.1 Livealth Company Information
13.12.2 Livealth Nefopam Hydrochloride Injection Product Offered
13.12.3 Livealth Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Livealth Main Business Overview
13.12.5 Livealth Latest Developments
13.13 JM Lifesciences
13.13.1 JM Lifesciences Company Information
13.13.2 JM Lifesciences Nefopam Hydrochloride Injection Product Offered
13.13.3 JM Lifesciences Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 JM Lifesciences Main Business Overview
13.13.5 JM Lifesciences Latest Developments
13.14 TAJ PHARMA
13.14.1 TAJ PHARMA Company Information
13.14.2 TAJ PHARMA Nefopam Hydrochloride Injection Product Offered
13.14.3 TAJ PHARMA Nefopam Hydrochloride Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 TAJ PHARMA Main Business Overview
13.14.5 TAJ PHARMA Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Nefopam Hydrochloride Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Nefopam Hydrochloride Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 1ml/Piece
Table 4. Major Players of 2ml/Piece
Table 5. Global Nefopam Hydrochloride Injection Sales by Specification (2017-2022) & (K Units)
Table 6. Global Nefopam Hydrochloride Injection Sales Market Share by Specification (2017-2022)
Table 7. Global Nefopam Hydrochloride Injection Revenue by Specification (2017-2022) & ($ million)
Table 8. Global Nefopam Hydrochloride Injection Revenue Market Share by Specification (2017-2022)
Table 9. Global Nefopam Hydrochloride Injection Sale Price by Specification (2017-2022) & (US$/Unit)
Table 10. Global Nefopam Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 11. Global Nefopam Hydrochloride Injection Sales Market Share by Application (2017-2022)
Table 12. Global Nefopam Hydrochloride Injection Revenue by Application (2017-2022)
Table 13. Global Nefopam Hydrochloride Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Nefopam Hydrochloride Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Nefopam Hydrochloride Injection Sales by Company (2020-2022) & (K Units)
Table 16. Global Nefopam Hydrochloride Injection Sales Market Share by Company (2020-2022)
Table 17. Global Nefopam Hydrochloride Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Nefopam Hydrochloride Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Nefopam Hydrochloride Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Nefopam Hydrochloride Injection Producing Area Distribution and Sales Area
Table 21. Players Nefopam Hydrochloride Injection Products Offered
Table 22. Nefopam Hydrochloride Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nefopam Hydrochloride Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Nefopam Hydrochloride Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Nefopam Hydrochloride Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Nefopam Hydrochloride Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Nefopam Hydrochloride Injection Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Nefopam Hydrochloride Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Nefopam Hydrochloride Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Nefopam Hydrochloride Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Nefopam Hydrochloride Injection Sales by Country (2017-2022) & (K Units)
Table 34. Americas Nefopam Hydrochloride Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Nefopam Hydrochloride Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Nefopam Hydrochloride Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Nefopam Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 38. Americas Nefopam Hydrochloride Injection Sales Market Share by Specification (2017-2022)
Table 39. Americas Nefopam Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 40. Americas Nefopam Hydrochloride Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Nefopam Hydrochloride Injection Sales by Region (2017-2022) & (K Units)
Table 42. APAC Nefopam Hydrochloride Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Nefopam Hydrochloride Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Nefopam Hydrochloride Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Nefopam Hydrochloride Injection Sales by Specification (2017-2022) & (K Units)
Table 46. APAC Nefopam Hydrochloride Injection Sales Market Share by Specification (2017-2022)
Table 47. APAC Nefopam Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 48. APAC Nefopam Hydrochloride Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Nefopam Hydrochloride Injection Sales by Country (2017-2022) & (K Units)
Table 50. Europe Nefopam Hydrochloride Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Nefopam Hydrochloride Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Nefopam Hydrochloride Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Nefopam Hydrochloride Injection Sales by Type (2017-2022) & (K Units)
Table 54. Europe Nefopam Hydrochloride Injection Sales Market Share by Specification (2017-2022)
Table 55. Europe Nefopam Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 56. Europe Nefopam Hydrochloride Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Nefopam Hydrochloride Injection Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Nefopam Hydrochloride Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Nefopam Hydrochloride Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Nefopam Hydrochloride Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Nefopam Hydrochloride Injection Sales by Specification (2017-2022) & (K Units)
Table 62. Middle East & Africa Nefopam Hydrochloride Injection Sales Market Share by Specification (2017-2022)
Table 63. Middle East & Africa Nefopam Hydrochloride Injection Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Nefopam Hydrochloride Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Nefopam Hydrochloride Injection
Table 66. Key Market Challenges & Risks of Nefopam Hydrochloride Injection
Table 67. Key Industry Trends of Nefopam Hydrochloride Injection
Table 68. Nefopam Hydrochloride Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Nefopam Hydrochloride Injection Distributors List
Table 71. Nefopam Hydrochloride Injection Customer List
Table 72. Global Nefopam Hydrochloride Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Nefopam Hydrochloride Injection Sales Market Forecast by Region
Table 74. Global Nefopam Hydrochloride Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Nefopam Hydrochloride Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Nefopam Hydrochloride Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Nefopam Hydrochloride Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Nefopam Hydrochloride Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Nefopam Hydrochloride Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Nefopam Hydrochloride Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Nefopam Hydrochloride Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Nefopam Hydrochloride Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Nefopam Hydrochloride Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Nefopam Hydrochloride Injection Sales Forecast by Specification (2023-2028) & (K Units)
Table 85. Global Nefopam Hydrochloride Injection Sales Market Share Forecast by Specification (2023-2028)
Table 86. Global Nefopam Hydrochloride Injection Revenue Forecast by Specification (2023-2028) & ($ Millions)
Table 87. Global Nefopam Hydrochloride Injection Revenue Market Share Forecast by Specification (2023-2028)
Table 88. Global Nefopam Hydrochloride Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Nefopam Hydrochloride Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Nefopam Hydrochloride Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Nefopam Hydrochloride Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Tianjin Kingyork Pharmaccuticals Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Tianjin Kingyork Pharmaccuticals Nefopam Hydrochloride Injection Product Offered
Table 94. Tianjin Kingyork Pharmaccuticals Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Tianjin Kingyork Pharmaccuticals Main Business
Table 96. Tianjin Kingyork Pharmaccuticals Latest Developments
Table 97. Sinopharm Ronshyn Pharmaceutical Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Sinopharm Ronshyn Pharmaceutical Nefopam Hydrochloride Injection Product Offered
Table 99. Sinopharm Ronshyn Pharmaceutical Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sinopharm Ronshyn Pharmaceutical Main Business
Table 101. Sinopharm Ronshyn Pharmaceutical Latest Developments
Table 102. Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical Nefopam Hydrochloride Injection Product Offered
Table 104. Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical Main Business
Table 106. Shanghai Hyundai Hassen (Shangqiu) Pharmaceutical Latest Developments
Table 107. Yangtze River Pharmaceutical Group Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Yangtze River Pharmaceutical Group Nefopam Hydrochloride Injection Product Offered
Table 109. Yangtze River Pharmaceutical Group Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Yangtze River Pharmaceutical Group Main Business
Table 111. Yangtze River Pharmaceutical Group Latest Developments
Table 112. Wanbangde Pharmaceutical Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Wanbangde Pharmaceutical Nefopam Hydrochloride Injection Product Offered
Table 114. Wanbangde Pharmaceutical Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Wanbangde Pharmaceutical Main Business
Table 116. Wanbangde Pharmaceutical Latest Developments
Table 117. Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical Nefopam Hydrochloride Injection Product Offered
Table 119. Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical Main Business
Table 121. Shanghai JINDI Jiuzhou (Anyang) Pharmaceutical Latest Developments
Table 122. Henan Tongyuan Pharmaceutical Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Henan Tongyuan Pharmaceutical Nefopam Hydrochloride Injection Product Offered
Table 124. Henan Tongyuan Pharmaceutical Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Henan Tongyuan Pharmaceutical Main Business
Table 126. Henan Tongyuan Pharmaceutical Latest Developments
Table 127. Fuzhou FU Yao Pharmaceutical Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Fuzhou FU Yao Pharmaceutical Nefopam Hydrochloride Injection Product Offered
Table 129. Fuzhou FU Yao Pharmaceutical Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Fuzhou FU Yao Pharmaceutical Main Business
Table 131. Fuzhou FU Yao Pharmaceutical Latest Developments
Table 132. Jumpcan Pharmaceutical Group Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Jumpcan Pharmaceutical Group Nefopam Hydrochloride Injection Product Offered
Table 134. Jumpcan Pharmaceutical Group Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Jumpcan Pharmaceutical Group Main Business
Table 136. Jumpcan Pharmaceutical Group Latest Developments
Table 137. Shandong FANGMING Pharmaceutical Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. Shandong FANGMING Pharmaceutical Nefopam Hydrochloride Injection Product Offered
Table 139. Shandong FANGMING Pharmaceutical Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Shandong FANGMING Pharmaceutical Main Business
Table 141. Shandong FANGMING Pharmaceutical Latest Developments
Table 142. Xuzhou Ryen Pharmaceutical Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 143. Xuzhou Ryen Pharmaceutical Nefopam Hydrochloride Injection Product Offered
Table 144. Xuzhou Ryen Pharmaceutical Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Xuzhou Ryen Pharmaceutical Main Business
Table 146. Xuzhou Ryen Pharmaceutical Latest Developments
Table 147. Livealth Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 148. Livealth Nefopam Hydrochloride Injection Product Offered
Table 149. Livealth Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Livealth Main Business
Table 151. Livealth Latest Developments
Table 152. JM Lifesciences Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 153. JM Lifesciences Nefopam Hydrochloride Injection Product Offered
Table 154. JM Lifesciences Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. JM Lifesciences Main Business
Table 156. JM Lifesciences Latest Developments
Table 157. TAJ PHARMA Basic Information, Nefopam Hydrochloride Injection Manufacturing Base, Sales Area and Its Competitors
Table 158. TAJ PHARMA Nefopam Hydrochloride Injection Product Offered
Table 159. TAJ PHARMA Nefopam Hydrochloride Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. TAJ PHARMA Main Business
Table 161. TAJ PHARMA Latest Developments
List of Figures
Figure 1. Picture of Nefopam Hydrochloride Injection
Figure 2. Nefopam Hydrochloride Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nefopam Hydrochloride Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Nefopam Hydrochloride Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Nefopam Hydrochloride Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 1ml/Piece
Figure 10. Product Picture of 2ml/Piece
Figure 11. Global Nefopam Hydrochloride Injection Sales Market Share by Specification in 2021
Figure 12. Global Nefopam Hydrochloride Injection Revenue Market Share by Specification (2017-2022)
Figure 13. Nefopam Hydrochloride Injection Consumed in Hospital Pharmacy
Figure 14. Global Nefopam Hydrochloride Injection Market: Hospital Pharmacy (2017-2022) & (K Units)
Figure 15. Nefopam Hydrochloride Injection Consumed in Retail Pharmacy
Figure 16. Global Nefopam Hydrochloride Injection Market: Retail Pharmacy (2017-2022) & (K Units)
Figure 17. Global Nefopam Hydrochloride Injection Sales Market Share by Application (2017-2022)
Figure 18. Global Nefopam Hydrochloride Injection Revenue Market Share by Application in 2021
Figure 19. Nefopam Hydrochloride Injection Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Nefopam Hydrochloride Injection Revenue Market Share by Company in 2021
Figure 21. Global Nefopam Hydrochloride Injection Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Nefopam Hydrochloride Injection Revenue Market Share by Geographic Region in 2021
Figure 23. Global Nefopam Hydrochloride Injection Sales Market Share by Region (2017-2022)
Figure 24. Global Nefopam Hydrochloride Injection Revenue Market Share by Country/Region in 2021
Figure 25. Americas Nefopam Hydrochloride Injection Sales 2017-2022 (K Units)
Figure 26. Americas Nefopam Hydrochloride Injection Revenue 2017-2022 ($ Millions)
Figure 27. APAC Nefopam Hydrochloride Injection Sales 2017-2022 (K Units)
Figure 28. APAC Nefopam Hydrochloride Injection Revenue 2017-2022 ($ Millions)
Figure 29. Europe Nefopam Hydrochloride Injection Sales 2017-2022 (K Units)
Figure 30. Europe Nefopam Hydrochloride Injection Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Nefopam Hydrochloride Injection Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Nefopam Hydrochloride Injection Revenue 2017-2022 ($ Millions)
Figure 33. Americas Nefopam Hydrochloride Injection Sales Market Share by Country in 2021
Figure 34. Americas Nefopam Hydrochloride Injection Revenue Market Share by Country in 2021
Figure 35. United States Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Nefopam Hydrochloride Injection Sales Market Share by Region in 2021
Figure 40. APAC Nefopam Hydrochloride Injection Revenue Market Share by Regions in 2021
Figure 41. China Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Nefopam Hydrochloride Injection Sales Market Share by Country in 2021
Figure 48. Europe Nefopam Hydrochloride Injection Revenue Market Share by Country in 2021
Figure 49. Germany Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Nefopam Hydrochloride Injection Revenue Growth 2017-2022 ($ Millions)
Figure 5
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)